Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

about

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

Item

http://www.wikidata.org/entity/Q36389087

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@ast

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@en

type

Item

label

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@ast

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@en

prefLabel

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@ast

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@en

P1476

Preclinical Rodent Toxicity Studies for Long Term Use of Ceftriaxone

@en

P2093

Amy Swartz Ellrodt

http://www.w3.org/2001/XMLSchema#string

David J Greenblatt

http://www.w3.org/2001/XMLSchema#string

Elena Ratti

http://www.w3.org/2001/XMLSchema#string

James D Berry

http://www.w3.org/2001/XMLSchema#string

Jeremy M Shefner

http://www.w3.org/2001/XMLSchema#string

Lorena Loci

http://www.w3.org/2001/XMLSchema#string

P2860

Prolonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms

Design and initial results of a multi-phase randomized trial of ceftriaxone in amyotrophic lateral sclerosis

Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis.

Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial.

Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis

P304

1396-1403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.TOXREP.2015.09.010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Merit E Cudkowicz

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283667169

http://www.w3.org/2001/XMLSchema#string

P698

26705515

http://www.w3.org/2001/XMLSchema#string

P932

4685718

http://www.w3.org/2001/XMLSchema#string